Methodological concerns in a trial of ziprasidone and olanzapine

Letter/Communication

Ryan M Carnahan and Paul J Perry

The American journal of psychiatry, Vol.162(7), pp.1391; author reply 1391-1391

07/2005

DOI: 10.1176/appi.ajp.162.7.1391-a

PMID: 15994736

View Online

Anti-Anxiety Agents - administration & dosage

Piperazines - administration & dosage

Randomized Controlled Trials as Topic - methods

Antipsychotic Agents - adverse effects

Bias

Humans

Thiazoles - administration & dosage

Thiazoles - therapeutic use

Schizophrenic Psychology

Thiazoles - adverse effects

Randomized Controlled Trials as Topic - standards

Dose-Response Relationship, Drug

Lorazepam - therapeutic use

Antipsychotic Agents - therapeutic use

Anti-Anxiety Agents - therapeutic use

Drug Therapy, Combination

Drug Administration Schedule

Lorazepam - administration & dosage

Piperazines - therapeutic use

Piperazines - adverse effects

Antipsychotic Agents - administration & dosage

Benzodiazepines - administration & dosage

Research Design - standards

Benzodiazepines - adverse effects

Schizophrenia - drug therapy

Benzodiazepines - therapeutic use

Title: Subtitle: Methodological concerns in a trial of ziprasidone and olanzapine
Creators: Ryan M Carnahan - University of Iowa, Epidemiology
Paul J Perry - University of Iowa, Pharmacy
Resource Type: Letter/Communication
Publication Details: The American journal of psychiatry, Vol.162(7), pp.1391; author reply 1391-1391
DOI: 10.1176/appi.ajp.162.7.1391-a
PMID: 15994736
NLM abbreviation: Am J Psychiatry
ISSN: 0002-953X
eISSN: 1535-7228
Publisher: United States
Language: English
Date published: 07/2005
Academic Unit: Pharmacy; Epidemiology; Injury Prevention Research Center
Record Identifier: 9983995170602771

32 Record Views